Cargando…

Impaired Bone Matrix: The Key to Fragility in Type 2 Diabetes?

Detalles Bibliográficos
Autores principales:	Hernandez, Christopher J, Stein, Emily M, Donnelly, Eve
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Commentaries
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8208657/ https://www.ncbi.nlm.nih.gov/pubmed/33693826 http://dx.doi.org/10.1210/clinem/dgab150

Ejemplares similares

Fragile, handle with care: refining a key concept for global health and development
por: Diaconu, Karin, et al.
Publicado: (2023)

Type 2 diabetes and bone fragility in children and adults
por: Faienza, Maria Felicia, et al.
Publicado: (2022)

Pathophysiology and Management of Type 2 Diabetes Mellitus Bone Fragility
por: Eller-Vainicher, C., et al.
Publicado: (2020)

Diabetes and Bone Fragility
por: Romero-Díaz, Camila, et al.
Publicado: (2020)

Type 2 diabetes mellitus and bone fragility: Special focus on bone imaging
por: Choi, Yong Jun, et al.
Publicado: (2016)

Type 1 Diabetes and Bone Fragility: Links and Risks
por: Starup-Linde, Jakob, et al.
Publicado: (2019)

mSphere of Influence: the Key Role of Neutrophils in Tuberculosis and Type 2 Diabetes Comorbidity
por: Mayer Bridwell, Anne E.
Publicado: (2021)

Living with Type 2 Diabetes: Patient Commentary in Response to the Paper ‘SGLT2 Inhibitors in Type 2 Diabetes Management: Key Evidence and Implications for Clinical Practice’
por: Evans, Marc
Publicado: (2018)

Diabetes Mellitus-induced Bone Fragility
por: Kanazawa, Ippei, et al.
Publicado: (2018)

Best Practices in Fragile X Syndrome Treatment Development
por: Erickson, Craig A., et al.
Publicado: (2018)

Treatment of type 2 diabetes in chronic kidney disease: a case for linagliptin in the treatment of diabetes in severe renal impairment
por: Scott, David
Publicado: (2013)

Functional MRI Signal Fluctuations: A Preclinical Biomarker for Cognitive Impairment in Type 2 Diabetes?
por: Belfort-DeAguiar, Renata, et al.
Publicado: (2014)

Delineating the transcriptional atlas for impaired insulin secretion: A window into type 2 diabetes pathophysiology
por: Li, Jian, et al.
Publicado: (2023)

Skeletal Fragility in Type 2 Diabetes Mellitus
por: Starup-Linde, Jakob, et al.
Publicado: (2018)

Osteoporosis and Fragility Fractures in Type 2 Diabetes
por: Chiodini, Iacopo, et al.
Publicado: (2020)

Fragile phagocytes: FMRP positively regulates engulfment activity
por: Logan, Mary A.
Publicado: (2017)

Trends, Changes, and Disruptions: The Fragile Economics of Cancer Treatments
por: Abraham, Ivo
Publicado: (2023)

Multiscale alterations in bone matrix quality increased fragility in steroid induced osteoporosis
por: Karunaratne, A., et al.
Publicado: (2016)

Biochemical Markers of Bone Fragility in Patients With Diabetes
por: Meier, Christian, et al.
Publicado: (2023)

The COVID-19 Pandemic: Lessons for Financially Fragile and Aging Societies
por: van Dalen, Hendrik P, et al.
Publicado: (2020)

Control of visceral leishmaniasis in East Africa: fragile progress, new threats
por: Dahl, Elin Hoffmann, et al.
Publicado: (2021)

Pulse-wave velocity is associated with cognitive impairment in haemodialysis patients
por: Miller-Hodges, Eve, et al.
Publicado: (2017)

Diabetes: impaired damage control
por: Schaper, N. C., et al.
Publicado: (2011)

The complex pathophysiology of bone fragility in obesity and type 2 diabetes mellitus: therapeutic targets to promote osteogenesis
por: Bathina, Siresha, et al.
Publicado: (2023)

A fragile but critical link: a commentary on the importance of government-academy relationships
por: Brown, Adalsteinn, et al.
Publicado: (2018)

The fragile healthcare system in Lebanon: sounding the alarm about its possible collapse
por: Bou Sanayeh, Elie, et al.
Publicado: (2023)

Diagnosis and management of bone fragility in diabetes: an emerging challenge
por: Ferrari, S.L., et al.
Publicado: (2018)

Mouse models and the interpretation of human GWAS in type 2 diabetes and obesity
por: Cox, Roger D., et al.
Publicado: (2011)

Impairment of type H vessels by NOX2-mediated endothelial oxidative stress: critical mechanisms and therapeutic targets for bone fragility in streptozotocin-induced type 1 diabetic mice
por: Hu, Xiao-Fan, et al.
Publicado: (2021)

Prioritising the global response to curb the spread of COVID-19 in the fragile settings of the Global South
por: Osama, Tasnime, et al.
Publicado: (2020)

Trained immunity: A key player of “metabolic memory” in diabetes
por: Naruse, Keiko
Publicado: (2021)

Insulin Resistance and Type 2 Diabetes
por: Taylor, Roy
Publicado: (2012)

Psychological resilience, fragility and the health workforce: lessons on pandemic preparedness from Liberia and Sierra Leone
por: Dean, Laura, et al.
Publicado: (2020)

Public Health Genomics Approach to Type 2 Diabetes
por: Khoury, Muin J., et al.
Publicado: (2008)

Is cognitive impairment the fourth diabetic microvascular complication?
por: Kawamura, Takahiko, et al.
Publicado: (2011)

Which trial do we need? Management of elderly, fragile, fully vaccinated patients hospitalized for SARS-CoV-2 infection
por: Trøseid, Marius, et al.
Publicado: (2023)

A proteomic approach to obesity and type 2 diabetes
por: López-Villar, Elena, et al.
Publicado: (2015)

The residual cardiorenal risk in type 2 diabetes
por: Giugliano, Dario, et al.
Publicado: (2021)

Exercise in type 2 diabetes: to resist or to endure?
por: Roden, M.
Publicado: (2012)

Pharmacoepigenetics in type 2 diabetes: is it clinically relevant?
por: Ling, Charlotte
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2o01qm67qjsghnsjrr6vtkslsq